Search

The Leeds Teaching Hospitals NHS Trust and Imperial College London

Biomedical Research and Training Institute, Zimbabwe, Imperial College London, University of Lincoln, University College London Hospitals, University of Copenhagen, University of Washington, Heidelberg University, and Frank Tanser, Professor

UK Medical Research Council (MRC), European and Developing Countries Clinical Trials Partnership (EDCTP), Research Center Borstel, Imperial College London, University of Stellenbosch, National Taiwan University, Namibian National Tuberculosis and Leprosy Programme (NTLP), UK Foreign, Commonwealth & Development Office (FCDO), and Mareli Claassens, Associate research professor

Imperial College London and Brunel University

Chinese University of Hong Kong, University of Edinburgh, University of Seville, Imperial College London, Icahn School of Medicine at Mount Sinai, Fundacio Clinic Barcelona, Sorbonne University, and Newcastle University

Royal Marsden NHS Foundation Trust and Imperial College London

All India Institute of Medical Sciences, New Delhi, Imperial College London, and Dr. Dorairaj Prabhakaran, Executive Director

West Hertfordshire Hospitals NHS Trust, Queen's University, Belfast, The University of Queensland, University Hospital of Wales, Edinburgh Napier University, King's College London, University of Warwick, University of Manchester, Royal Surrey County Hospital NHS Foundation Trust, University College, London, NHS Lothian, Imperial College London, and University of Cambridge

Imperial College London and Liverpool Women's NHS Foundation Trust

Imperial College London

Merck Sharp & Dohme LLC, Imperial College London, and University of Liverpool

Children's Hospital Medical Center, Cincinnati, University of North Carolina, Chapel Hill, George Washington University, Emory University, University of Southampton, Imperial College London, and Wanda Phipatanakul, Professor of Pediatrics

University of Cambridge, University of Oxford, University of Edinburgh, University of Leeds, Imperial College London, Medical Research Council, British Heart Foundation, Swansea University, British Heart Foundation Data Science Centre, and Prof. Maya H. Buch, Professor of Rheumatology and Director of Experimental Medicine at the Centre for Musculoskeletal Research, University of Manchester

Children's Hospital of Philadelphia, University of Botswana, Centers for Disease Control and Prevention, University of Utah, Imperial College London, Botswana-UPenn Partnership, and Ebbing Lautenbach, Principal Investigator

University of Bordeaux, Instituto Nacional de Saúde, Mozambique, ADERA, University of Stellenbosch, Imperial College London, Institut de Recherche pour le Développement (IRD), University of Sheffield, Ludwig-Maximilians - University of Munich, Ministry of Health, Zambia, Ministry of Health, Mozambique, Eduardo Mondlane University, European and Developing Countries Clinical Trials Partnership (EDCTP), and Chishala Chabala, Principal Investigator

Karolinska Institutet, Centro Hospitalar Lisboa Ocidental, Heinrich-Heine University, Duesseldorf, ASST Santi Paolo e Carlo, Imperial College London, Vilnius University Hospital Santaros Klinikos, University of Rome Tor Vergata, Bach Mai Hospital, Kenya Medical Research Institute, Hospital Regional de Alta Especialidad 'Dr. Juan Graham Casasus', and University Hospitals Dorset NHS Foundation Trust

Imperial College London

King's College Hospital NHS Trust, Imperial College London, London North West Healthcare NHS Trust, Imperial College Healthcare NHS Trust, Guy's and St Thomas' NHS Foundation Trust, and Calum Moulton, Chief Investigator

Cardiff University, University of Oxford, and Imperial College London

South London and Maudsley NHS Foundation Trust, Imperial College London, University College, London, Oxford Health NHS Foundation Trust, NHS Greater Glasgow and Clyde, and Birmingham Women's and Children's NHS Foundation Trust

Cambridge University Hospitals NHS Foundation Trust, Wellcome Trust (211100/Z/18/Z), Imperial College London, National Institute for Health Research, United Kingdom, and Jason Tarkin, Wellcome Clinical Research Career Development Fellow

University of Leicester, University of Oxford, Neonatal Data Analysis Unit, Imperial College London, and BLISS charity

King's College London, University College, London, Imperial College London, University of Cambridge, University of Southampton, University of Nottingham, University of Leicester, Frimley Health NHS Foundation Trust, Newcastle University, University of Bristol, and Asthma and Lung UK

University College, London, City, University of London, and Imperial College London

University of Liverpool, University College, London, Imperial College London, Pancreatic Cancer Research Fund, and Ospedale San Raffaele

Imperial College London

Imperial College London and Trauma and Orthopaedics Research Charity

Imperial College London, Royal Free and University College Medical School, The Leeds Teaching Hospitals NHS Trust, Hannover Medical School, University of Siena, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria di Sassari, and Bichat Hospital

St George's, University of London, Guy's and St Thomas' NHS Foundation Trust, Imperial College London, King's College Hospital NHS Trust, and BRITISH LIVER TRUST

National Institute for Health Research, United Kingdom, King's College London, and Imperial College London

Imperial College London

Imperial College London, King's College London, University of Oxford, and Universität Münster

Gilead Sciences and Imperial College London

Imperial College London, University College Dublin, University of Limerick, Cystic Fibrosis Registry of Ireland, Erasmus Medical Center, Medizinische Hochschule Brandenburg Theodor Fontane, Queen's University, Belfast, Teagasc, The Hospital for Sick Children, St. James's Hospital, Ireland, and Amsterdam UMC

RM Partners West London Cancer Alliance, Institute of Cancer Research, United Kingdom, and Imperial College London

Imperial College London

National Institute for Health Research, United Kingdom, University College London Hospitals, Northern Care Alliance NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, Royal Devon and Exeter NHS Foundation Trust, University of Bristol, University of Dundee, London School of Hygiene and Tropical Medicine, King's College London, University Hospital, Rouen, and Imperial College London

University Cheikh Anta Diop of Daka, Tehran University of Medical Sciences, The University of Global Health Equity, Imperial College London Diabetes Centre, National Institutes of Biomedical Innovation, Health and Nutrition., University of Aberdeen, and John R. Speakman, Principal Investigator

Van Andel Institute - Stand Up To Cancer Epigenetics Dream Team, University of Southern California, Imperial College London, University of Copenhagen, Odense University Hospital, Technical University of Denmark, Aalborg University Hospital, and Kirsten Grønbæk, Professor, MD, DMSc

Van Andel Institute - Stand Up To Cancer Epigenetics Dream Team, Karolinska University Hospital, Skane University Hospital, Sahlgrenska University Hospital, Sweden, University of Southern California, Imperial College London, University of Copenhagen, Zealand University Hospital, Aalborg University Hospital, Odense University Hospital, Technical University of Denmark, Aarhus University Hospital, Uppsala University Hospital, and Kirsten Grønbæk, Professor, MD, DMSc

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, European Institute of Oncology, University of Alberta, Imperial College London, University of Debrecen, Lithuanian University of Health Sciences, and Milena Pitashny, MD, Director of Clinical and Research Microbiome Center

University of Cambridge, University of Bristol, University College, London, King's College London, Imperial College London, St George's, University of London, University of Glasgow, Wellcome Trust, and Dr Ian B Wilkinson, Head of Division, Division of Experimental Medicine & Immunotherapeutics

The Thrombolysis in Myocardial Infarction Study Group, Harvard University, Imperial College London, University of Oslo, and Amgen

University of Aberdeen, NHS Greater Glasgow and Clyde, University of East Anglia, Nottingham City Hospital, Swansea University, Newcastle University, University of Cambridge, NHS Sunderland Clinical Commissioning Group, Liverpool School of Tropical Medicine, Royal Brompton & Harefield NHS Foundation Trust, University College London Hospitals, Liverpool Heart and Chest Hospital NHS Foundation Trust, Imperial College London, Red Graphic, Eramol (UK) Ltd., WGK Clinical Services Ltd., Sealed Envelope Ltd., National Institute for Health Research, United Kingdom, and Dr Ian B Wilkinson, Professor of Therapeutics

Imperial College London

Imperial College London

Imperial College London, Queen's University, Belfast, Monash University, and Stuart Mazzone, Professor of Neuroscience

Mercedes AMG PETRONAS Formula One Team and Imperial College London

Edwards Lifesciences and Imperial College London

Keele University, Imperial College London, University of Oxford, and University of Aberdeen